Lv1
30 积分 2023-07-20 加入
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
3小时前
待确认
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
10天前
已完结
Prognostic analysis and liver metastases relevant factors after gastric and hepatic surgical treatment in gastric cancer patients with metachronous liver metastases: a population-based study
22天前
已完结
Benign and Malignant Tumors of the Pituitary Gland
1个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
1个月前
已完结
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
3个月前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
3个月前
已完结
Diagnosis and Treatment of Metastatic Colorectal Cancer
5个月前
已完结
Colorectal cancer
5个月前
已完结
皖公网安备34019202002308
